Infective endocarditis triangle.. Is it the time to revisit infective endocarditis susceptibility and indications for its antibiotic prophylaxis?
Eur J Prev Cardiol
.
2019 Nov;26(16):1771-1774.
doi: 10.1177/2047487319856126.
Epub 2019 Jun 10.
Authors
Giuseppe Calcaterra
1
,
Antonio Crisafulli
2
,
Paolo Guccione
3
,
Giovanni Di Salvo
4
,
Pier P Bassareo
5
Affiliations
1
University of Palermo, Italy.
2
Department of Medical Sciences and Public Health, Sports Physiology Laboratory, University of Cagliari, Italy.
3
Department of Paediatric Cardiology and Cardiac Surgery Bambino Gesù Paediatric Hospital, Rome, Italy.
4
Royal Brompton and Harefield NHS Foundation Trust, Imperial College of London, UK.
5
University College of Dublin, Mater Misericordiae University Hospital, Republic of Ireland.
PMID:
31180759
DOI:
10.1177/2047487319856126
No abstract available
Publication types
Review
MeSH terms
Anti-Bacterial Agents / therapeutic use*
Antibiotic Prophylaxis / methods*
Endocarditis / mortality
Endocarditis / prevention & control*
Global Health
Humans
Prognosis
Survival Rate / trends
Substances
Anti-Bacterial Agents